Print

AVEG 014A/B

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB env/gag/pol Vaccine (TCB-3B)

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) April 13, 1994
TBC-3B Vaccinia env and gag/pol IIIB
TBC-3B Viral Vector - Pox
USA 18
NCT00000767
https://clinicaltrials.gov/show/NCT00000767